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ABSTRACT
The secretory capacity of growth hormone (GH) and prolactin
(PRL) ceils prepared from rats flown in space on the 12.5 day
mission of Cosmos 1887 and the 14 day mission of Cosmos 2044 was
evaluated in several post-flight tests on Earth. The results showed
statistically significant and repeatable decrements in hormone
release, especially when biological assays (rather than immunological
assays) were used in the tests. Significant and repeatable
intracellular changes in GH cells from the flight animals were also
found; most important were increases in the GH-specific cytoplasmic
staining intensities and cytoplasmic areas occupied by hormone. Tail
suspension of rats for 14 days, an established model for mimicking
musculo-skeletal changes seen in spaeeflown rats, resulted in some
changes in GH and PRL cell function that were similar to those from
spaceflown animals. Our results add to a growing body of data that
describe deconditioning of physiological systems in spaceflight and
provide insights into the time frame that might be required for
readaptation of the GH/PRL cell system upon return to Earth.
Index terms: Growth hormone, prolactin, microgravity
1INTRODUCTION
Changes in the musculoskeletal, immune, vascular and
endocrine systems of the rat occur as a result of short-term space-
flight (10). Since pituitary gland growth hormone (GH) plays a role
in the control of these systems, and since the results of an earlier
spaceflight mission (Spacelab 3, 1985) showed that GH cell function
was compromised in a number of post-flight tests (13), we repeated
and extended the 1985 experiment in two subsequent spaceflights:
the 12.5 day mission of Cosmos 1887 (in 1987) and the 14 day
mission of Cosmos 2044 (in 1989). The results of these later two
flight experiments are the subject of this report. They document
repeatable and significant changes in the GH cell system of the
spaceflown rat in several post-flight tests. Results from the Cosmos
2044 flight show changes in the prolactin (PRL) cell system as well.
Methods and Material_
Details of the 1887 and 2044 missions, hereafter referred to as
experiments 1 and 2, respectively, are described elsewhere (10, 11,
30). In each experiment, anterior pituitary glands from 5 flight (F)
and 5 synchronous control rats (C) were removed aseptically and
transported in individual teflon vials from the landing site to the
laboratory in Moscow. Results of extensive pre-flight testing
indicated that storage of intact pituitary glands for 24-26 hrs at
room temperature in Spinners Minimum Essential Medium (SMEM)
2containing 0.1% bovine serum albumin, 25 mM Hepes buffer
(pH 7.4), 0.2% NaHCO3, gentamycin sulfate (10 _tg/ml), and penicillin
(100 U/ml)/streptomycin (100 t_g/ml) was optimal for subsequent
preparation of cells with high viability (>90%) and good yield
(=l.7x106) (data not shown). Each of these parameters is within the
range of those reported for preparation of fresh cells from the rat
pituitary (16). During transport of the glands in the above medium
(22 ml/vial) the temperature was maintained between 23-24°C.
Cells were prepared from individual glands by trypsinization
(8) and kept separate during culture tests to permit statistical anal-
ysis of the data. However, some tests required large numbers of
cells, so samples from each gland within a group were pooled. The
protocol for both flight experiments was similar except that in Exp. 2
an additional group of animals was subjected to tail suspension on
Earth for 14 days in order to see how well the results from this
approach (22) mimicked actual spaceflight (Figure 1). In each
control experiment, 5 Wistar male rats/group were housed under
conditions detailed in (10, 30).
Specific method_ (individual _lands)
Cell preparation: Cells were prepared by trypsinization,
counted by hemocytometry and their viability determined as
described previously (15).
.t_d]__g..u]lll_: Cells (2.5x105 - Exp. 1, 5x104 - Exp. 2) were
cultured in 250 111 of modified Eagle's medium (o_MEM) containing 5%
calf serum and antibiotics (27) or in chemically defined medium con-
taining insulin, transferrin, selenium and other trace elements in
3MEM base (27) in 96-well plates for 3 days in a humidified atmo-
sphere of 5% CO2:95% air at 37°C. There were 3 or 4 wells of cells
from each gland. After 3 days the media were saved, stored at -20°C
and fresh media added for an additional 3 day culture.
Intracellul_r hormone extraction: Cells were incubated
overnight in 0.01 N NaHC03 at 4°C, particulate material centrifuged
(1000 xg, 30 min) and the supernatant fraction frozen for later
hormone analyses. Greater than 90% of intracellular GH and
prolactin (PRL) is extracted under these conditions (8).
Hormone _ssay_: Concentrations of immunoreactive GH and
PRL in culture media and extracts were determined by established
enzyme immunoassays (6, 7, 26). The antisera for GH and PRL have
been validated; their cross reactivities are <0.3% at the final dilutions
used (I:80,000-GH; I:40,000-PRL) (15). The tibial line bioassay of
Greenspan (9) was used to measure concentrations of bioactive GH.
These were 4 point assays using a bovine GH (1.5 IU/mg) prepara-
tion as standard. These data are expressed in terms of rat GH
(3.0 IU/mg). PRL bioassays used were either the NB-2 lymphoma
cell division assay originally described by Tanaka et al. (29)or the
IL-2 receptor assay of Mukherjee et aI. (24). Results of all these
assays are expressed in terms of rat GH Standard (B-11) or PRL
Standard (B-6) kindly provided by the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) and the National Hormone
and Pituitary Program (University of Maryland School of Medicine).
Morphology: Immunocytochemistry for GH cells (2.5x104)
attached to poly-l-lysine-coated coverslips was done using a
diaminobenzidine procedure (15). These preparations were used for
1) determining GH cell percentages (Exp. 2 only) using a scoring
method on coded samples by 6 investigators, and 2)determining the
cytoplasmic area occupied by GH, a procedure which involved image
analysis that uses a digitized color image of the stained cell to quan-
tify both the area of the cell stained and the intensity of the stain.
An OASYS optical analysis system (Lemont Scientific, State College,
PA) was used to digitize the image and colorize according to inten-
sities within the system's 256 gray levels (19) so that the area of GH-
specific cytoplasmic staining could be quantitated. Care was taken to
maintain constant light settings, condenser height, and aperture size
in addition to normalizing variations in light using a light meter
placed at the level of the camera.
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Specific Methods (pooled cells)
Cell implants: In order to determine the amount of bioactive
GH secreted from cells of flight animals after implantation into
hypophysectomized rats, the hollow fiber method of Hymer et al. was
used (18). In this case, 2x105 cells were loaded into 10 mm long XM
50 Amicon fibers (n=10/treatment group) and implanted into the
lateral cerebral ventricles of 100 g male rats 7 days after pituitary
gland removal. Ten days post-implantation, the tibia of the host
animals were prepared for staining and measurements of epiphyseaI
cartilage width taken with an ocular micrometer. Fiber placement
was verified by visual inspection of brain slices. This implantation
procedure was done only in Exp. 1.
Fl0w cytometry: Cells (2x105) were fixed in suspension
(PBS/azide buffered 4.0% formalin), their membranes permeabilized
with 0.1% Triton X-100, incubated in GH or PRL antisera (1:10,000)
overnight, followed by incubation in FITC-conjugated antisera,
counterstained with propidium iodide and analyzed on an Epics flow
cytometer (Model 753) exactly as described (15). Analysis included
the determination of GH and PRL cell percentages (30,000 cells/trial),
intensity of hormone fluorescence, size (forward angle light scatter,
FALS) and cytoplasmic granularity (perpendicular light scatter, PLS).
Statistical analysis: When appropriate, data were analyzed by
ANOVA and the Students t-test using p<0.05 as a significant differ-
ence.
Results
l
Hormone contents of storage (transport) media
Q__H_: The concentrations of GH and PRL in the 30 hr. storage
media of F, C, and tail suspended (TS) animal groups are shown in
Table 1. These levels reflect hormone release from the glands into
the media during tissue transportation. In Exp. 1 there was a signif-
icant increase in levels of immunoreactive GH (i-rGH) in F vials
relative to the C group; in Exp. 2 levels of i-rGH were significantly
decreased in the flight group. However, in the F groups of both
experiments, there was a marked reduction in levels of biologically
active GH (b-rGH) secreted into the medium. Transport media from
glands of the TS animals were markedly elevated in i-rGH, but were
again significantly lower in b-rGH content.
PRL: Concentrations of PRL in the transport media, measured
by immunoassay (i-rPRL), NB-2 bioassay or IL-2R assay (b-rPRL)
6were usually similar between all treatment groups; however,
transport media from the TS group usually contained lower amounts
of PRL (Table 1).
Characteristics of GH and PRL cell_: The yield of cells from individual
glands of most groups averaged 1.9x106 with viabilities >90%
(Table 2). The reason for lower yield and viability in the TS group is
unknown. Relative to the GH cells in the C group, F GH cells were
a) lower in frequency in Exp. 2 but not affected in Exp. 1;
b) markedly and consistently increased (2-fold) in GH-specific
immunofluorescence staining intensities; c)slightly larger, as
evidenced by increased FALS signal; d)not different in PLS signal,
and e)consistently and significantly different in the cytoplasmic
area occupied by GH (Table 2). As with F cells, GI-I cells from the TS
group were less frequent than those in the C group; however, in the
other parameters they were more like C cells. An example of the
increased GH-specific cytoplasmic staining intensity seen in F cells
from Exp. 1 is shown in Fig. 2.
Relative to the PRL cells in the C group, F PRL cells were
a) inconsistent in differences in their frequency distribution and PLS
laser light scatter signals; b)somewhat larger (FALS), and c)not
different in staining intensities nor in cytoplasmic area occupied by
PRL. PRL cells from the TS group again tended to be lower in these
characteristics than those in the F and C groups.
In both experiments the intraeellular concentrations of i-rGI-I
before or after culture tended to be similar between all treatment
groups; however, the intraeellular concentrations of b-rGH in the F
group, both before and after the culture, were always lower than the
7corresponding C group. This was also true for cells from the TS
group. Similar measurements for intracellular PRL were not possible
due to limited sample size; however no difference in initial PRL
content was seen between the F and C groups in Exp. 1.
Release of GH from F cells post-flight: In general, levels of i-rGH in
media of the first 3 day and second 3 day cultures were not signifi-
cantly different between treatment groups. The limited sensitivity
of the tibial line bioassay precluded analysis of b-rGH in media of
individual culture wells. However, the levels of b-rGH in pooled cul-
ture media from F or TS cells were so low that they were either
below the assay sensitivity (Exp. 1) or were reduced by *50%
relative to those in the C media (Exp. 2).
The design of Exp. 1, but not Exp. 2, also allowed us to test the
ability of the F cells to secrete b-rGH upon implantation into the
cerebral ventricles of hypophysectomized rats. As seen in Table 1,
GH secretion from post-flight F ceils in this in vivo test was one-half
of that produced by the C cell implants.
Release of PRL from F Cells post-flight: Release of PRL, by either
immunoassay or the lymphoma cell bioassay, was not significantly
different between the ceils in the F, C, and TS groups. However, cells
from both the F and TS groups released significantly less PRL when
the IL-2R bioassay was used.
DISCUSSION
The first objective of experiments I (Cosmos 1887) and 2
(Cosmos 2044) was to determine whether our earlier findings on the
SL-3 mission done in 1985 (13) were repeatable and statistically
significant. A second objective was to determine whether the
biological (B) and immunological (I) potencies of the GH and PRL
molecules secreted from the flight cells during various post-flight
trials were similar. The rationale for this objective is based on
reports that the B/I activity ratio of hormone preparations are not
necessarily one (5); therefore a marked change in the activity of one
form as a result of spaceflight might help identify one hormonal
mechanism underlying the cause(s) of microgravity-indueed
osteopenia, muscle atrophy, suppression of the immune system, etc.
A third objective of experiment 2 was to test the effects of tail
suspension on the same parameters that we chose to test with the
flight cells. Tail suspension is an established model for mimicked
microgravity (22) but the fidelity of the mimic is not completely
defined. Previous studies from our laboratories show that tail
suspension results in partial suppression of in vitro release of GH
from pituitary GH cells prepared post suspension (14, 23). The
Cosmos 2044 mission offered us the unique opportunity to test
within the same experiment the effects of tail suspension on the
same functional and morphological parameters that we did on the
flight ceils so that the results could be compared directly with actual
flight data.
9In Figs. 3 and 4, a comparison of the post-flight secretory
activities of GH and PRL cells with that of their ground-based coun-
terparts is presented as ratios of F/C responses. It is interesting that
in every spaceflight sample in which a GH bioassay measurement
was made the F/C ratio was always <1 (7/7), and the magnitude of
the suppression was usually on the order of 50-75%. On the other
hand, GH secretory responses measured by immunoassay were
obviously inconsistent; about half of the time they were lower (4/8)
than responses from the control groups. It is also interesting that the
GH secretory responses patterns between the TS and flight cells in
Exp. 2 are very similar (cf. Fig 3C vs. 3D). This similarity (together
with data of previous studies (14, 23)) clearly establishes the utility
of the tail suspension model as a means of mimicking spaceflight on
hormone release and this experimental approach can therefore be
expected to aid considerably in the design of future spaceflight
experiments.
The issue of the dichotomy between the activities of secreted
b-rGH and i-rGH, initially reported in 1974 (5), is obviously
important to understanding the mechanism(s) underlying these
microgravity-induced changes. Ongoing studies from our
laboratories have established a)that a subpopulation of GH cells
preferentially releases b-rGH in vitro and in vivo, (12) and b) that
aggregate forms of the 22 K GH molecule have enhanced hormone
biopoteney (8). We hypothesize that exposure to mierogravity could
alter the secretory activity of a subpopulation of GH cells, perhaps
mediated through changes in intraeellular packaging of the hormone
molecule. The Cosmos experiments offer three clues to unraveling
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mechanism(s) underlying the GH secretory defect. First, the cerebral
ventricles of the hypophysectomized rat contain GRF, a peptide which
normally regulates GH release from the somatotroph via cell surface
receptors. The finding that F cells did not respond to GRF in the rat
ventricles as well as the S cells (as evidenced by tibial line responses
in the hypophysectomized host) argues that a receptor or post-
receptor defect occurs in a GH cell subpopulation which does not
recover under the conditions of Exp. 1. This idea is supported by
results of a previous study which showed that GH cells prepared
from tail suspended animals did not respond to physiological
concentrations of GRF in terms of in vitro release of b-rGH as well as
cells from non-suspended animals (14). Second, cytoplasmic
secretory GH granules are associated with a complex network of
microtubules (25). An increase in the cytoplasmic area occupied by
GH (and presumably secretory granules) in F cells (Table 2) could be
interpreted to reflect "relaxation" of that network. Third, high
molecular weight aggregates of GH are weakly immunoreactive;
however, chemical reduction with mercaptoethanol enhances
immunoreactivity several-fold (8). The increased
immunofluorescent staining intensity of F cells (Table 2) could reflect
less S-S bridging between GH molecules; the consequence would be a
loss in GH biopoteney.
Most of the intracellular GH in the mammalian pituitary gland
is stored in 0.3 _tm secretory granules as disulfide-linked aggregates
of high molecular weight. These granules are capable of stimulating
long bone growth when they are injected into hypophysectomized
rats (3,17). If microgravity decreases the packing density of the
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intragranular GH molecules, increased exposure of epitopes would
result in increased cytoplasmic GH immunofluorescence and
decreased biopotency of the hormone. In this regard, the
repeatability of experiments 1 and 2 is striking and is considered
significant. Two recently published theoretical studies suggest the
plausibility of our hypothesis that low gravity could affect hormone
packaging within cytoplasmic secretory granules. In one (1)
Albrecht-Buehler shows how polymerization forces within a cell
could be sufficiently large to "sense" perturbations in the cell
environment directly. In the other (21) Kondepudi shows the
importance of treating ceils as systems in non-equilibruim states
when considering the issue of gravity and ceils. Specifically his
analysis also shows that organelles in the size range of pituitary
secretory granules may be able to "sense" perturbations in the cell
environment (e.g. low gravity).
It is interesting that the post-flight secretory responses of the
PRL ceils paralleled those of the GH cells in the sense that the biologi-
cal activity of secreted PRL (IL-2R assay) was also suppressed as a
result of flight or tail suspension while the immunological assays
gave spurious results (Fig. 4). While differing physiological
conditions are known to affect the B/I activity ratio of secreted PRL
(28), the molecular mechanisms involved are much less clearly
defined. Since no major intracellular changes were found in the PRL
ceils after flight or tail suspension, or in GH cells after tail suspension,
we can only suggest that effects of these treatments on packaging
and secretion must be only part of the mechanism(s) that accounts
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for the repeatable effect on one endpoint, viz. decreased biological
activity of secreted b-rPRL (IL-2R) and b-rGH.
As seen in Fig. 3, the times that elapsed between the landing of
the vehicle after spaceflight and the preparation of pituitary cells
was vastly different between the two missions. A number of other
factors have been examined by investigators involved in both the
1887 and 2044 missions to see if certain other variables could affect
experimental results. These have included possible effects of launch
and vibration, humidity, light, cabin temperatures, cages, water, food
consumption and stress. Analyses show that these factors cannot
explain the general results reported in the two spaceflight
experiments (10,11). The similarity of our results (Fig. 3) clearly
establish the repeatability and statistical significance of the effects of
microgravity on the pituitary Gt-I cell system postflight.
Deconditioning of physiological systems in spaceflight is well docu-
mented (10); the time frame for readaptation of these systems on
return to Earth's gravity is not. Our data show that the GH cells have
not recovered in their ability to secrete b-rGH up to 2 weeks post-
flight, the longest period studied thus far.
There is a growing awareness that the biological and immuno-
logical potencies of hormones and growth factors are not necessarily
the same and that the physiological state of the organism can affect
these activity ratios. Recent demonstrations of the importance of
heat shock proteins in processing molecules destined for export (2,
4), and their activation by external environment (e.g. heat, exercise,
(20)), may provide important clues for probing into the
mechanism(s) underlying the changes in the GH cell system reported
13
here. Equally plausible are microgravity-driven changes in GRF
receptors and/or microtubules in the GH cell. The limited oppor-
tunities for spaceflight experimentations are partially offset by the
fidelity of some of the responses observed in the GH cells prepared
from the tail suspended rat. Studies are underway to search for such
mechanism(s) in this mimicked model of microgravity.
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Parameter
Table 1
Release of GH and PRL from Pituitary Cells of Rats
Previously Flown in Space for 12.5 (Exp. 1) or 14 (Exp. 2) Days
Experiment I Experiment 2
Cosmos 1887 Cosmos 2044 Tail
Control Flight Control Flight Suspended
GH
Transport media
i-rGH (ng/ml)
b-rGH (I.tg/ml)
Basal secretion
i-rGH (ng/1000 GH ceUs)-3 day
i-rGH (rig/1000 GH ceII._)-6 day
b-KSH (l.tg/ml) - 3+6 day
Implant secretion
" brGH(_ rde_ed)
PRL
Transportmedia
i-rPRL (ng/ml)
b-rPRL 0qB-2) (nglml)
b-rPRL ([L-2R) (ng/ml)
Basal secretion (ng/1000 PRL cells)
i-rPRL - 3 day
i-rPRL - 6 day
b-rPRL (NB-2) - 3 day
b-rPRL (FIB-2) - 6 day
b-rPRL (IL-2R) - 3 day
1550 + 190 1950_+ 100" 160.2 + 10.6 127.5 + 9.2* 318.8 + 33.7**
2.88 1.13'** 2.73 0.58* 0.60*
(2.76 - 2.99) (I.03 - 1.28) (2.38 - 3.14) (0.52 - 0.67) (0.58 - 0.69)
57.2 + 4 62.2 + 5 25.29 + 3.31 26.81 + 3.84 36.8 + 4.0
142.9 + 7 73.0 + 10' 48.13 + 4.89 61.37 + 6.95 70.1 ± 7.1"
2.34 <<0.780"1 3.86 1.78" 2.61"
(2.03 - 2.63) (3.42 - 4.35) (1.63 - 1.94) (2.43 - 2.76)
2.2 1.0 ND ND ND
(1.7 - 2.7) (0.9 - 1.1)
307+45 351_+63 145.4+ 16.2 113.6+ 12.4 56.1 +7.3"**
122 + 26 188 + 17 203.5 + 56.4 172.7 + 23.5 75.0 ± 9.9**
ND ND 320.3 ± 38.5 203.0 ± 41.3 191.5 ± 26.4
20A -+0.8 10.5 ± 1.0" 27.9 ± 1.9 24.3 + 2.4 35.1 ± 7.8
29.1 ± 3 16.2 ± 0.2 53.9 + 4.1 41.8 _+4.3 79.9 ± 16.2
32.1 + 6 7.8 + 0.8 18.4 + 5.7 16.6 ± 2.9 22.9 ± 6.0
47.7 ± 13.9 12.7 + 2.5* 14.0 ± 6.2 20.8 + 5 7.0 ± 2.3
ND ND 12.8 ± 1.1 6.3 ± 0.2*** 9.0 ± 2.0**
19
b-rPRL (_L-2R) - 6 day ND ND 15.6+ 0.6 10.5+0.5"** 5.5 + 0.5***
Footnote to Table 1.
Transport media contains hormone released from intact pituitary glands during
the 24-30 hrs. in transit from the landing site to the laboratory in Moscow.
Basal _ecretiQn represents hormone released into culture wells over two
consecutive 3 day periods. Data are expressed on the basis of the number of GH
or PRL cells seeded.
Jmplant _ecretion represents the amount of GH released from cells previously
loaded into hollow fibers and implanted into the cerebral ventricle of
hypophysectomized rats over a 15 day period. Tibial epiphyseal plate widths
were compared to those in other hypophysectomized rats which had received
bovine GI-I for 4 days in order to estimate concentrations of hormone secreted
from implant. 95% confidence limits are shown in ().
i-rGH/PRL = immunoreactive growth hormone/prolactin; b-rGH/rPRL =
biologically active growth hormone/prolactin; b-rPRL (NB-2) = prolactin activity
detected by lymphoma cell bioassay (26); b-rPRL (IL-2R) = prolactin activity
detected by interleukin-2 receptor assay (21); ND = assay not done; - indicates
insufficent sample volume; data represent averages + standard error of mean;
*p<0.05, **p<0.01, ***p<0.001 relative to control, tEpiphyseal plate widths not
different than those from saline-injected control animals.
2O
Table 2
Characteristics of GH and PRL Cells Prepared From Pituitaries of
Rats Previously Flown in Space for 12.5 (Exp. 1) or 14 (Exp. 2) Days
Parameter
Experiment 1
Cosmos 1887
Control Flight
Experiment 2
Cosmos 2044 Tail
Control Flight Suspended
General
cen yield
viability
GH
%(flow cytometry)
%(Icc)
fluorescence intensity (marker index)
FALS
PLS
% area occupied by GH
E_cts
initial i-rGH (ng/1000 GH ceils)
_tial b-rGH 0tg/rr_)
final i-rGH (ng/1000 GH cells)
nnal b-rGH _g/ml)
PR.__LL
%(flow cytometry)
marker index
FALS
PLS
% area occupied by PRL
1.68 :t: 0.1 1.98 + 0.2
90 + 0.9 93 + 0.7
23 27
ND ND
13.1 24.5
151 181
145 145
37.1 + 4.7 49.9 ± 4.1"
61 + 17 40 + 17
9.13 4.18§
1.8 + 0.1 2.2 + 0.1" 1.67 + 0.08
94.2 + 0.6 92.3 + 0.9 83.8 + 1.3"**
36 24 27.6
26.3 ± 2.8 20.2 ± 2.9 16.1 + 2.0*
4.4 8 4.3
32 40 31
37 41 38
36.6 ± 2.5 48.6 :t: 2.3* 34.1 ± 1.5
2.11
(1.63 - 2.74)
m m
<<0.780"1. <<0.780"t
22 +9.0 8.6 ± 0.8 18 ± 2 22 ± 3 18.3 ± 2.3
2.05 1.63§ 3.31 <<0.780"1.1" <<0.780"1"
(3.20 - 3.49)
32 47 33.3 34.4 22.6
5.1 4.1 5.7 4.7 3.7
24 40 12 21 10
64 92 25 21 21
- - 25.5_+3.2 32.9+_6.1 32.1 +_7.8
21
initial intracellular PRL
(ng/lO00 PRL cells)
0.24 + 0.02 0.22 + 0.05
Footnote to Table 2.
Percentages of GH/PRL cells were determined by flow cytometry (30,000 ceils
counted/trial) or, in one case, by immunoeytochemistry as well. Intensity of
cytoplasmic fluorescence hormone staining (see Fig. 2) were quantified by flow
cytometry using the marker index method, which is based on fluorescence
intensity converted to voltage. The ratio of voltages of stained to unstained
ceils = marker index. FALS and PLS (forward angle light scatter and
perpendicular light scatter, respectively) determined by flow cytometry.
represent peak channels of size (FALS) and cytoplasmic granularity (PLS),
respectively (15). Area of GH in cytoplasm of GH cells were determined by
image analysis and intracellular hormone levels before and after culture
determined on alkaline extracts of cells (see Materials and Methods).
§Significance could not be determined for these samples due to insufficient
sample volume.
Values
22
Figure Legends
Figure 1
Figure 2
Figure 3
Figure 4
Experimental protocol followed for Experiments 1
(Cosmos 1887) and 2 (Cosmos 2044). See Materials and
Methods for specific assays.
Photomicrographs of GH cells (yellow) from Exp. 1 stained
by an immunofluorescence procedure (see Materials and
Methods) (magnification = 670x). Top: control; bottom:
flight.
Comparison of post-flight secretory responses of GH ceils
from rats flown on the Spacelab 3 mission in 1985;
Cosmos 1887 (Exp. 1); Cosmos 2044 (Exp. 2); and tail
suspended animals (TS-Exp. 2) expressed as the ratios of
experimental to control. Data for the SL-3 experiment
previously published in (I4); permission to use these
data obtained from American J. Physiology.
Comparison of post-flight secretory responses of PRL ceils
from rats flown on the Cosmos 1887 mission (Exp. 1);
Cosmos 2044 mission (Exp. 2) and tail suspended animals
(TS-Exp. 2) expressed as the ratio of experimental to
control.
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